Clinical Trial Update: Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

View source ↗

Summary

The clinical trial evaluating lonafarnib in breast cancer has been terminated; the update does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lonafarnib (lonafarnib)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Breast Cancer | Status: TERMINATED